Correlation Between Visa and Phoenix Biotech
Can any of the company-specific risk be diversified away by investing in both Visa and Phoenix Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Phoenix Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Phoenix Biotech Acquisition, you can compare the effects of market volatilities on Visa and Phoenix Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Phoenix Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Phoenix Biotech.
Diversification Opportunities for Visa and Phoenix Biotech
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Visa and Phoenix is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Phoenix Biotech Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phoenix Biotech Acqu and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Phoenix Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phoenix Biotech Acqu has no effect on the direction of Visa i.e., Visa and Phoenix Biotech go up and down completely randomly.
Pair Corralation between Visa and Phoenix Biotech
If you would invest 28,365 in Visa Class A on August 29, 2024 and sell it today you would earn a total of 2,817 from holding Visa Class A or generate 9.93% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.55% |
| Values | Daily Returns |
Visa Class A vs. Phoenix Biotech Acquisition
Performance |
| Timeline |
| Visa Class A |
| Phoenix Biotech Acqu |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Visa and Phoenix Biotech Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and Phoenix Biotech
The main advantage of trading using opposite Visa and Phoenix Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Phoenix Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phoenix Biotech will offset losses from the drop in Phoenix Biotech's long position.| Visa vs. American Express | Visa vs. Morningstar Unconstrained Allocation | Visa vs. Sitka Gold Corp | Visa vs. MSCI ACWI exAUCONSUMER |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |